Lymphedema of the lower extremity: Is it genetic or nongenetic?

Clinical Pediatrics

Volumn 46, Issue 9, 2007, Pages 835-841

  Shinawi, Marwan ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Genetic; Lymphangiogenesis; Lymphedema; Lymphoscintigraphy; Syndromic

Indexed keywords

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; GOLD STANDARD; HUMAN; LABORATORY TEST; LYMPHEDEMA; LYMPHEDEMA PRAECOX; LYMPHOSCINTIGRAPHY; PHYSICAL EXAMINATION;

ADOLESCENT; FEMALE; HUMANS; LYMPHEDEMA;

EID: 35048893801     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922807303545     Document Type: Article

References (24)

1. Szuba A., Rockson SG Lymphedema: classification, diagnosis and therapy. Vasc Med. 1998 ; 3: 145-156.
2. Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics. 1985 ; 76: 206-218.
3. Szuba A., Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003 ; 44: 43-57.
4. Williams WH, Witte CL, Witte MH, McNeill GC Radionuclide lymphangioscintigraphy in the evaluation of peripheral lymphedema. Clin Nucl Med. 2000 ; 25: 451-464.
5. Witte CL, Witte MH, Unger EC, et al. Advances in imaging of lymph flow disorders. Radiographics. 2000 ; 20: 1697-1719.
6. Tiwari A., Cheng KS, Button M., Myint F., Hamilton G. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg. 2003 ; 138: 152-161.
7. Northup KA, Witte MH, Witte CL Syndromic classification of hereditary lymphedema. Lymphology. 2003 ; 36: 162-189.
8. An A., Rockson SG The potential for molecular treatment strategies in lymphatic disease. Lymphat Res Biol. 2004 ; 2: 173-181.
9. Cueni LN, Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol. 2006 ; 12: 2167-2177.
10. Oliver G. Lymphatic vasculature development. Nat Rev Immunol. 2004 ; 4: 35-45.
11. Witte MH, Bernas MJ, Martin CP, Witte CL Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc Res Tech. 2001 ; 55: 122-145.
12. Brice G., Child AH, Evans A., et al. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet. 2005 ; 42: 98-102.
13. Karkkainen MJ, Ferrell RE, Lawrence EC, et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000 ; 25: 153-159.
14. Fang J., Dagenais SL, Erickson RP, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet. 2000 ; 67: 1382-1388.
15. Mellor RH, Brice G., Stanton AW, et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation. 2007 ; 115: 1912-1920.
16. Levinson KL, Feingold E., Ferrell RE, Glover TW, Traboulsi EI, Finegold DN Age of onset in hereditary lymphedema. J Pediatr. 2003 ; 142: 704-708.
17. Irrthum A., Devriendt K., Chitayat D., et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedematelangiectasia. Am J Hum Genet. 2003 ; 72: 1470-1478.
18. Finegold DN, Kimak MA, Lawrence EC, et al. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet. 2001 ; 10: 1185-1189.
19. Ruocco V., Schwartz RA, Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol. 2002 ; 47: 124-127.
20. Cerri A., Gianni C., Corbellino M., Pizzuto M., Moneghini L., Crosti C. Lymphangiosarcoma of the pubic region: a rare complication arising in congenital non-hereditary lymphedema. Eur J Dermatol. 1998 ; 8: 511-514.
21. Rockson SG Lymphedema. Am J Med. 2001 ; 110: 288-295.
22. Casley-Smith JR Benzo-pyrones in the treatment of lymphoedema. Int Angiol. 1999 ; 18: 31-41.
23. Bernas MJ, Witte CL, Witte MH ; International Society of Lymphology Executive Committee. The diagnosis and treatment of peripheral lymphedema: draft revision of the 1995 Consensus Document of the International Society of Lymphology Executive Committee for discussion at the September 3-7, 2001, XVIII International Congress of Lymphology in Genoa, Italy. Lymphology. 2001 ;34: 84-91.
24. Yoon YS, Murayama T., Gravereaux E., et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest. 2003, 11: 717-725.